Xiushi biopharma is an innovation-driven technology company, focused on breaking through the polypeptide biosynthesis technology and large-scale manufacturing.
0+
projects
Polypeptide development experience over 10 years
0+
m2
Research and pilot center more than 10000 square meters
0+
m2
Intelligent drug manufacturing base more than 20000 square meters
Peptide CMC (Chemistry, Manufacturing, and Controls) development refers to the research and development work on the chemical, manufacturing, and quality control aspects of peptide drugs. CMC development is an important part of the drug development process, aimed at ensuring the quality, safety, and efficacy of peptide drugs.
Peptide Drug Substance refers to the process of bringing the developed Active Pharmaceutical Ingredient (API) to the market and commercializing its production. API is the active ingredient in drugs that has therapeutic effects and is an essential component in the pharmaceutical process.
Functional Polypeptide are short chain protein molecules with specific biological functions. Due to their extensive bioactivity, biocompatibility and stability, functional peptides have great potential applications in drug development, food raw materials and biological materials.
Peptide discovery services refer to the professional services provided to clients for the discovery and design of peptide drugs. These services are typically offered by biotechnology companies, drug development organizations, or specialized peptide discovery companies.
News
Update to the latest synthetic biology and polypeptide products
